Depressive Disorder, Major: all 2,805 studies
Page 25 of 29. Open to participants first (565), then studies with results posted, then the rest; newest registration first within each.
- Life Goals Behavioral Change to Improve Outcomes for Veterans With Serious Mental IllnessCompletedNCT01244854Not applicable
- Oxytocin and Tibolone Adjuncts in Treatment Resistant Depression - A Pilot StudyStatus unknownNCT01239888Phase 1
- Single IV Dose of GLYX-13 in Patients With Treatment-Resistant DepressionCompletedNCT01234558Phase 2
- Online Self-help for Depressed Patients Awaiting PsychotherapyTerminatedNCT01226238Not applicable
- Retrospective Study Evaluating The Current Utilization Of Desvenlafaxine Succinate Sustained-Release (Pristiq) Among Psychiatrists And Primary Care Physicians In The Treatment Of Patients With Major Depressive DisorderCompletedNCT01221935
- Study to Assess the Distribution, Metabolism and Excretion of [14C]AZD6765 After a Single-Dose Intravenous AdministrationCompletedNCT01217645Phase 1
- A Comparison of Cognitive and Dynamic Therapy for Depression in Community SettingsCompletedNCT01207271Not applicable
- Pharmacogenomics Studies of AntidepressantsStatus unknownNCT01204086Phase 4
- Testing the Effectiveness of a Computer-based Program for DepressionCompletedNCT01203683Phase 3
- Repetitive Transcranial Magnetic Stimulation(rTMS) in the Treatment of DepressionStatus unknownNCT01198561
- Slow-wave Sleep Deprivation in DepressionCompletedNCT01189591Not applicable
- Effects of Seroquel XR on Sleep Architecture in Patients With Major Depressive DisorderWithdrawnNCT01189318Phase 2
- Antidepressant Adherence Via AD_IVRCompletedNCT01188135Phase 3
- Biomarkers of Antidepressant Treatment in Adolescents With Major Depression (The Adolescents MDD Study)CompletedNCT01185977Phase 4
- Creatine Augmentation in Veterans With SSRI-Resistant Major DepressionWithdrawnNCT01175616Phase 4
- Open-label Long Term (52 Weeks) Safety and Tolerability of Agomelatine Sublingual Tablets in Major Depressive Disorder (MDD)TerminatedNCT01156415Phase 3
- Schema Focused Therapy for Chronic DepressionCompletedNCT01153867Not applicable
- Long-term Bilateral Theta Burst Stimulation for the Treatment of Major DepressionCompletedNCT01153139Phase 2/3
- Transcranial Direct Current Stimulation to Treat Major Depressive DisorderCompletedNCT01149889Phase 2/3
- Follow-up Study of Transcranial Direct Current Stimulation to Treat Major Depressive DisorderCompletedNCT01149213Phase 2/3
- Efficacy and Tolerability of Escitalopram and Duloxetine in Outpatients With Major Depressive DisorderCompletedNCT01148472Phase 4
- Computerized Information-Processing Bias Retraining in Depressed AdolescentsCompletedNCT01147913Phase 2
- The Effects and Mechanisms of Mindfulness Based Cognitive Therapy (MBCT) on Depressive Symptoms and Depression RelapseCompletedNCT01145872Phase 3
- Impact of Atypical Antipsychotic Therapy on Health Outcomes and Costs Among Patients With Major Depressive DisorderCompletedNCT01145313
- The Effect of Patient Cost-Sharing on Antidepressant and Adjunctive Therapy UseCompletedNCT01141400
- Outcomes in MEasurement-Based TreatmentCompletedNCT01141387
- Mothers With a History of Depression and Their 10-14 Year Old DaughtersCompletedNCT01129752
- Safety and Pharmacology Study of BMS-866949TerminatedNCT01124344Phase 1
- Fluoxetine Versus Fluoxetine Plus DU125530 in Major Depressive DisorderTerminatedNCT01119430Phase 2
- A Safety and Efficacy Study of JNJ26489112 in Patients With Treatment-Resistant Major Depressive DisorderTerminatedNCT01114698Phase 2
- NeuroStar TMS Therapy System: Utilization and OutcomesCompletedNCT01114477
- Efficacy, Safety and Tolerability of Agomelatine Sublingual Tablets in the Treatment of Major Depressive Disorder (MDD)CompletedNCT01110902Phase 3
- Efficacy, Safety and Tolerability of Agomelatine Sublingual Tablets in the Treatment of Major Depressive DisorderCompletedNCT01110889Phase 3
- Pioglitazone as an Adjunct for Moderate to Severe Depressive DisorderCompletedNCT01109030Phase 2/3
- Insulin Resistance in Patients With Major DepressionCompletedNCT01106313
- Neural Responses and Dysphoria: Modulation by a Pharmacological ProbeCompletedNCT01101685Phase 4
- Treatment of Severe Depressive Illness by Targeted Brain SurgeryCompletedNCT01101373
- Effects of Deep Brain Stimulation in Treatment Resistant Major DepressionCompletedNCT01095263Phase 1
- Biomarkers for Outcomes In Late-life Depression (BOLD)CompletedNCT01082237Phase 4
- Transcranial Direct Current Stimulation (tDCS) in the Treatment of Major Depressive Disorder (MDD)CompletedNCT01078948Not applicable
- Early Prediction of Fluoxetine ResponseCompletedNCT01075529Phase 4
- Prevention of Weight Gain in Early PsychosesCompletedNCT01075295Not applicable
- Mindfulness-based Behavioural Therapy (MIBT) Versus Psychodynamic Therapy for Patients With Major Depressive Disorder in Psychotherapeutic Day Treatment. A Randomised Clinical Pilot TrialStatus unknownNCT01070134Not applicable
- Light Therapy for Depression During PregnancyCompletedNCT01043289Not applicable
- A Trial Evaluating the Efficacy and Tolerability of SSR125543 in Outpatients With Major Depressive DisorderCompletedNCT01034995Phase 2
- Safety Study of F2695 SR in Major Depressive DisorderCompletedNCT01034267Phase 3
- Efficacy Study of Transcranial Direct Current Stimulation to Treat Major Depressive DisorderCompletedNCT01033084Phase 2/3
- Effect of Curcumin as Nutraceutical in Patients of DepressionCompletedNCT01022632Not applicable
- Stress Reduction Intervention for Enhancing Treatment Outcome for Depressed Minority PatientsCompletedNCT00998959Not applicable
- Neurocognitive Enhancement in Major Depressive DisorderCompletedNCT00998569Not applicable
- Cognitive Flexibility in Major Depression in the Course of Pharmacological and Psychotherapeutic TreatmentCompletedNCT00993876Not applicable
- Adjunctive Pregnenolone in Post-Traumatic Stress Disorder (PTSD) and Depression in Operations Enduring Freedom and Iraqi Freedom (OEF/OIF) VeteransWithdrawnNCT00993629Phase 2
- The Impact of Memantine on Electroconvulsive Therapy (ECT): Will it Improve Response and Protect Against Cognitive Problems?WithdrawnNCT00988663Not applicable
- rTMS for Adolescents and Young AdultsWithdrawnNCT00984087Phase 2
- N-methylglycine (Sarcosine) Treatment for DepressionCompletedNCT00977353Phase 2
- Magnetic Seizure Therapy (MST) for the Treatment of Major DepressionCompletedNCT00973934Phase 2
- Study of Supplementation of Antidepressants With Fish Oil to Improve Time to Clinical ResponseWithdrawnNCT00963196Not applicable
- Photobiomodulation to Alter Cerebral Blood Flow and to Affect the Emotional Status of Patients With Major DepressionCompletedNCT00961454Phase 1
- Light, Ion, and Fluoxetine Efficacy (LIFE) in DepressionCompletedNCT00958204Phase 3
- Neurophysiologic Predictors of Outcome With rTMS Treatment of Major Depressive DisorderCompletedNCT00956514Phase 4
- Quetiapine Prolong, Escitalopram and Hypothalamic-pituitary-adrenocortical (HPA) Axis Activity in Depressed PatientsCompletedNCT00953108Phase 3
- Assessment of Pituitary Adenylate Cyclase Activating Polypeptide-Brain Derived Neurotrophic Factor (PACAP-BDNF) Signaling System Involvement in Etiology and Treatment of Major DepressionCompletedNCT00944996Not applicable
- Study of Mindfulness-Based Cognitive TherapyCompletedNCT00943033Not applicable
- Comparison of Vitamin B12 Supplementation to Selective Serotonin Reuptake Inhibitor (SSRI) Versus SSRI Antidepressant Treatment AloneStatus unknownNCT00939718Not applicable
- A Comprehensive Intervention for Diabetes and Comorbid Depression in Primary CareCompletedNCT00939250Phase 4
- Assessment of Cognitive Functioning Before and After Treatment With DuloxetineCompletedNCT00933439Not applicable
- Citalopram Versus Citalopram Plus Pindolol in Major Depressive DisorderCompletedNCT00931775Phase 2
- GABA/Glutamate Balance in Temporal Lobe Epilepsy With and Without Major DepressionCompletedNCT00931619
- Mindfulness Based Cognitive Therapy and Antidepressant Medication in Recurrent DepressionCompletedNCT00928980Not applicable
- Evaluation of the Brainsway Deep Transcranial Magnetic Stimulation (TMS) H-Coil in the Treatment of Major Depression DisorderCompletedNCT00927173Not applicable
- Effect of Antidepressants on the Treatment for Korean Major Depressive Disorder PatientsTerminatedNCT00926835Phase 4
- Improving Representative Payeeship for People With Psychiatric Disabilities and Their FamiliesCompletedNCT00924976Not applicable
- Identifying Very Early Response to Seroquel Extended Release (XR) Augmentation for Major Depressive DisorderCompletedNCT00892463Phase 4
- Duloxetine for Major Depression in Peri-/Postmenopausal WomenStatus unknownNCT00889369Phase 4
- Desvenlafaxine Succinate (DVS) for Major Depressive Disorder (MDD) in Midlife Men and WomenStatus unknownNCT00888862Phase 3
- Antidepressant Effect of Deep Brain Stimulation in Parkinson's Disease PatientsCompletedNCT00885222Not applicable
- The Efficacy of Parent Involvement in the Treatment of Adolescent DepressionCompletedNCT00883519Phase 1/2
- Study Evaluating Effexor XR in Chinese Subjects With Major Depressive DisorderWithdrawnNCT00878748Phase 4
- Compare the Efficacy and Tolerability of the Combination of Aripiprazole and Selective Serotonin Reuptake Inhibitors (SSRIs) Used in Major DepressionCompletedNCT00873795Not applicable
- Practicing Alternative Techniques to Heal From Depression: The PATH-D StudyCompletedNCT00871299Not applicable
- Ultrabrief Pulsewidth Electroconvulsive Therapy (ECT)CompletedNCT00870805Phase 4
- Transcranial Direct Current Stimulation (tDCS) Augmentation by D-Cycloserine as a Treatment for DepressionCompletedNCT00869765Phase 2
- Long Term Safety and Tolerability of SR58611 in Patients With Major Depressive DisorderCompletedNCT00855530Phase 3
- Psychosocial Treatment of Depression in Parkinson's DiseaseStatus unknownNCT00853346Not applicable
- Cognitive Deficits in Major Depressive Disorder and Bipolar Disorder, Depressed Type: Prevalence and Improvement With Treatment of Depressive SymptomsCompletedNCT00844974Not applicable
- Efficacy Study of RX-10100 to Treat Major Depressive Disorder (MDD)CompletedNCT00839176Phase 2
- Acupuncture for Residual Insomnia Associated With Major Depressive DisorderCompletedNCT00838994Not applicable
- Efficacy and Safety of SR58611 Compared to Placebo and ParoxetineCompletedNCT00825058Phase 3
- Efficacy and Safety of One Single Dose of SR58611 Compared to Placebo and ParoxetineCompletedNCT00825019Phase 3
- An Eight-week Study of SSR411298 as Treatment for Major Depressive Disorder in Elderly PatientsCompletedNCT00822744Phase 2
- Associations Between Depression and Cardiovascular Disease - a Study of Patients With Late Onset DepressionCompletedNCT00818506
- The Effect of Fish Oil in Major Depressive DisorderCompletedNCT00816322Not applicable
- Eszopiclone Co-Administered With Escitalopram for Insomnia in Elderly Adults With Major Depressive DisorderCompletedNCT00813735Phase 4
- Neural Correlates of Psychodynamic Psychotherapy for DepressionCompletedNCT00812227Not applicable
- Contingency Management of Psychostimulant Abuse in the Severely Mentally IllCompletedNCT00809770Not applicable
- Evaluation of the H-coil Transcranial Magnetic Stimulation TMS Device - Safety and Feasibility Study for Acute and Maintenance Treatment in Major Depressive EpisodeCompletedNCT00807105Phase 2
- Physiologic Monitoring of Antidepressant ResponseCompletedNCT00792168Phase 4
- Study of Cerebral Function in Patients With Chronic Hepatitis C Infection (HCV/CNS)CompletedNCT00788918Not applicable
- Imaging Antidepressant vs. Cognitive Behavior Therapy Effects on Unipolar DepressionCompletedNCT00787501Phase 1
- Efficacy and Safety of Escitalopram Doses up to 50mg in Treatment of MDDCompletedNCT00785434Phase 4